Latest news
Boundless Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Fri, 07 Aug 2026 12:31:51 GMTBoundless Bio, Inc. 2Q 2026: Net loss $23.7M, EPS $(1.06) — 10-Q Summary - TradingViewTradingView · Fri, 07 Aug 2026 11:11:00 GMTBOLD: Definitive merger with Serapha Bio triggers major restructuring, higher losses, and special dividend - TradingViewTradingView · Fri, 07 Aug 2026 11:01:43 GMTBoundless Bio, Inc. Revenue Breakdown – NASDAQ:BOLD - TradingViewTradingView · Fri, 31 Jul 2026 18:12:41 GMTBoundless Bio Inc (BOLD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKeyTradingKey · Mon, 27 Jul 2026 18:40:54 GMTBOLD|Boundless Bio Inc|Price:2.500| - TradingKeyTradingKey · Mon, 27 Jul 2026 16:06:54 GMTBoundless Bio Inc (BOLD) Valuation: PE, PB & Fair Value Analysis - TradingKeyTradingKey · Mon, 27 Jul 2026 15:04:00 GMTBoundless Bio Inc (BOLD) Balance Sheet - TradingKeyTradingKey · Mon, 27 Jul 2026 13:57:18 GMT